KINDSTAR GLOBAL (09960) plans to acquire 100% equity of Guangzhou Kangcheng Weiye Biological Technology and AnchorDx Inc. respectively.

KINDSTAR GLOBAL (09960) announced that the company is in discussions to acquire 100% equity of Guangzhou Kangcheng Weiyue Biotechnology Co., Ltd. and AnchorDx Inc. As of the release of this announcement, the company has not signed any legally binding transaction documents regarding the proposed acquisitions. Based on the latest information available regarding the proposed acquisitions, it is expected that the proposed acquisitions will constitute a discloseable transaction for the company under Chapter 14 of the Listing Rules of The Stock Exchange of Hong Kong Limited.